ASTCT与USCLC临床实践建议:蕈样肉芽肿和Sézary综合征的异基因干细胞移植
INTRODUCTION: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma. While MF generally follows an indolent course, a subset of patients will experience progressive and/or treatment-refractory disease.…
要点
- 提出了MF/SS患者转诊考虑allo-HCT的共识标准。
- 明确了allo-HCT预处理方案和操作流程的推荐。
- 强调了移植前后多学科管理的重要性。
核心结论
- 该临床实践指南为MF/SS患者allo-HCT的决策提供了框架,并指出了未来前瞻性研究的方向。
研究设计与样本
- 采用德尔菲调查法,纳入来自美国的32名专家,包括皮肤科9名、移植血液/肿瘤科10名、非移植血液/肿瘤科8名和放射肿瘤科5名,共识定义为≥75%参与者同意。
关键数值与推荐
- 共识要求≥75%的参与者同意。
临床怎么用
- 临床医生可参考这些共识声明对MF/SS患者进行allo-HCT的转诊、预处理、移植时机选择及多学科管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma. While MF generally follows an indolent course, a subset of patients will experience progressive and/or treatment-refractory disease. SS is an aggressive cutaneous T-cell lymphoma associated with high morbidity and mortality secondary to immune compromise and opportunistic infection. Although allogeneic hematopoietic cell transplant (allo-HCT) is currently the only available potentially curative treatment modality for MF/SS and is included in the National Comprehensive Cancer Network and the American Society for Transplantation and Cellular Therapy treatment guidelines, there is no published guidance regarding referral criteria, timing and allo-HCT approach to help guide clinicians caring for these patients. METHODS: Delphi survey of 32 specialists in dermatology (n = 9), transplant hematology/oncology (n = 10), nontransplant hematology/oncology (n = 8), and radiation oncology (n = 5) from across the United States. Consensus required agreement of ≥75% of participants. RESULTS: Sixteen consensus statements were generated on 4 topics: 1) criteria for referral for consideration for allo-HCT, 2) allo-HCT preparative regimens and procedures, 3) disease status at the time of allo-HCT, and 4) multidisciplinary management in the pre- and post-transplant settings. CONCLUSION: These clinical practice guidelines provide a framework for decision-making regarding allo-HCT for MF/SS and highlight areas for future prospective investigation.
引用
- Goyal A, O'Leary D, Dabaja B, et al. ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome. J Am Acad Dermatol. 2025. PMID: 40199382. doi:10.1016/j.jaad.2025.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。